Advanced search
Publication Cover
International Journal of Neuroscience Volume 125, 2015 - Issue 9
Submit an article Journal homepage
1,851
Views
132
CrossRef citations to date
0
Altmetric
Meta-Analysis

Cerebrospinal fluid alpha-synuclein as a biomarker for Parkinson's disease diagnosis: a systematic review and meta-analysis

Liang GaoDepartment of Neurology, Guangdong Neuroscience Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China
,
Hongmei TangDepartment of Neurology, Guangdong Neuroscience Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China
,
Kun NieDepartment of Neurology, Guangdong Neuroscience Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China
,
Limin WangDepartment of Neurology, Guangdong Neuroscience Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China
,
Jiehao ZhaoDepartment of Neurology, Guangdong Neuroscience Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China
,
Rong GanDepartment of Neurology, Guangdong Neuroscience Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China
,
Jing HuangDepartment of Neurology, Guangdong Neuroscience Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China
,
Ruiming ZhuDepartment of Neurology, Guangdong Neuroscience Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China
,
Shujun FengDepartment of Neurology, Guangdong Neuroscience Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China
,
Zhenpeng DuanDepartment of Neurology, Guangdong Neuroscience Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China
,
Yuhu ZhangDepartment of Neurology, Guangdong Neuroscience Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, ChinaCorrespondence[email protected] [email protected]
&
Lijuan WangDepartment of Neurology, Guangdong Neuroscience Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, ChinaCorrespondence[email protected] [email protected]
 show all
Pages 645-654 | Received 13 Feb 2014, Accepted 01 Sep 2014, Published online: 02 Oct 2014

Citations (132)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Nicole Campese, Maria Francesca Beatino, Claudia Del Gamba, Elisabetta Belli, Linda Giampietri, Eleonora Del Prete, Alessandro Galgani, Andrea Vergallo, Gabriele Siciliano, Roberto Ceravolo, Harald Hampel & Filippo Baldacci. (2021) Ultrasensitive techniques and protein misfolding amplification assays for biomarker-guided reconceptualization of Alzheimer’s and other neurodegenerative diseases. Expert Review of Neurotherapeutics 21:9, pages 949-967.
Read now
Darren M. O’Hara, Suneil K. Kalia & Lorraine V. Kalia. (2020) Methods for detecting toxic α-synuclein species as a biomarker for Parkinson’s disease. Critical Reviews in Clinical Laboratory Sciences 57:5, pages 291-307.
Read now
Filippo Baldacci, Sonia Mazzucchi, Alessandra Della Vecchia, Linda Giampietri, Nicola Giannini, Maya Koronyo-Hamaoui, Roberto Ceravolo, Gabriele Siciliano, Ubaldo Bonuccelli, Fanny M. Elahi, Andrea Vergallo, Simone Lista, Filippo Sean Giorgi & Harald Hampel. (2020) The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases. Expert Review of Molecular Diagnostics 20:4, pages 421-441.
Read now
Kurt A. Jellinger. (2017) Potential clinical utility of multiple system atrophy biomarkers. Expert Review of Neurotherapeutics 17:12, pages 1189-1208.
Read now
Murat Kasap, Gurler Akpinar & Aylin Kanli. (2017) Proteomic studies associated with Parkinson’s disease. Expert Review of Proteomics 14:3, pages 193-209.
Read now

Articles from other publishers (127)

Ayushi Singhal, Rashmita Devi, Arpana Parihar & Raju Khan. 2024. Smart Diagnostics for Neurodegenerative Disorders. Smart Diagnostics for Neurodegenerative Disorders 61 80 .
Chaisak Dumrikarnlert, Lertchai Wachirutmangur, Suthipol Udomphanthurak, Chatchawan Rattanabannakit, Prachaya Srivanitchapoom & Vorapun Senanarong. (2023) Plasma Alpha Synuclein as a Potent Biomarker of Diseases with Synucleinopathies. Siriraj Medical Journal 75:12, pages 864-870.
Crossref
Nirosen Vijiaratnam & Thomas Foltynie. (2023) How should we be using biomarkers in trials of disease modification in Parkinson’s disease?. Brain 146:12, pages 4845-4869.
Crossref
Fardin Nabizadeh, Sara KamaliZonouzi & Maryam Noori. (2023) Cerebrospinal fluid biomarkers profile in scans without evidence of dopaminergic deficits (SWEDD). IBRO Neuroscience Reports 15, pages 320-326.
Crossref
Anuja Mishra, Mukti Agrawal, Aaliya Ali & Prakrati Garg. (2023) Uninterrupted real‐time cerebral stress level monitoring using wearable biosensors: A review. Biotechnology and Applied Biochemistry 70:6, pages 1895-1914.
Crossref
Yaxian Liu, Xiaoyi Wang, Giulia Campolo, Xiangyu Teng, Liming Ying, Joshua B. Edel & Aleksandar P. Ivanov. (2023) Single-Molecule Detection of α-Synuclein Oligomers in Parkinson’s Disease Patients Using Nanopores. ACS Nano 17:22, pages 22999-23009.
Crossref
Wojciech Paslawski & Per Svenningsson. (2023) Elevated ApoE, ApoJ and lipoprotein-bound α-synuclein levels in cerebrospinal fluid from Parkinson's disease patients – Validation in the BioFIND cohort. Parkinsonism & Related Disorders 116, pages 105765.
Crossref
Savannah M. Rocha, Kelly S. Kirkley, Debotri Chatterjee, Tawfik A. Aboellail, Richard J. Smeyne & Ronald B. Tjalkens. (2023) Microglia‐specific knock‐out of NF‐κB / IKK2 increases the accumulation of misfolded α‐synuclein through the inhibition of p62/ sequestosome ‐1‐dependent autophagy in the rotenone model of Parkinson's disease . Glia 71:9, pages 2154-2179.
Crossref
Eric T. Wong, Harry Rosenberg, Olivia Dawood, Lauren Hertan, Rafael A. Vega, Matthew Anderson & Erik J. Uhlmann. (2023) Lewy body disease as a potential negative outcome modifier of glioblastoma treatment: a case report. BMC Neurology 23:1.
Crossref
David G. Coughlin & David J. Irwin. (2023) Fluid and Biopsy Based Biomarkers in Parkinson’s Disease. Neurotherapeutics 20:4, pages 932-954.
Crossref
Pedro Carneiro, Simone Morais & Maria do Carmo Pereira. (2023) Biosensors for α-synuclein detection: Towards an improved diagnosis of Parkinson's disease. TrAC Trends in Analytical Chemistry, pages 117150.
Crossref
Yong Qi Leong, Rhun Yian Koh, Soi Moi Chye & Khuen Yen Ng. (2023) Unravelling the genetic links between Parkinson’s disease and lung cancer. Biological Chemistry 404:6, pages 551-567.
Crossref
Marc Carceles-Cordon, Dan Weintraub & Alice S. Chen-Plotkin. (2023) Cognitive heterogeneity in Parkinson’s disease: A mechanistic view. Neuron 111:10, pages 1531-1546.
Crossref
Federico Paolini Paoletti, Lorenzo Gaetani, Giovanni Bellomo, Elena Chipi, Nicola Salvadori, Chiara Montanucci, Andrea Mancini, Marta Filidei, Pasquale Nigro, Simone Simoni, Nicola Tambasco, Massimiliano Di Filippo & Lucilla Parnetti. (2023) CSF neurochemical profile and cognitive changes in Parkinson’s disease with mild cognitive impairment. npj Parkinson's Disease 9:1.
Crossref
Luis Concha-Marambio, Sandra Pritzkow, Mohammad Shahnawaz, Carly M. Farris & Claudio Soto. (2023) Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid. Nature Protocols 18:4, pages 1179-1196.
Crossref
Jun Yang, Ayotimofe Idowu, Liana Rosenthal & Xiaobo Mao. (2022) Parkinson's disease fluid biomarkers for differential diagnosis of atypical parkinsonian syndromes. Clinical and Translational Discovery 3:1.
Crossref
Artur M. Coutinho, Maria Gabriela Ghilardi, Ana Carolina P. Campos, Elba Etchebehere, Fernanda C. Fonoff, Rubens G. Cury, Rosana L. Pagano, Raquel C. R. Martinez & Erich T. Fonoff. (2023) Does TRODAT-1 SPECT Uptake Correlate with Cerebrospinal Fluid α-Synuclein Levels in Mid-Stage Parkinson’s Disease?. Biomedicines 11:2, pages 296.
Crossref
Elena A. Katunina, Victor Blokhin, Marina R. Nodel, Ekaterina N. Pavlova, Alexander L. Kalinkin, Valerian G. Kucheryanu, Leyla Alekperova, Marianna V. Selikhova, Mikhail Yu. Martynov & Michael V. Ugrumov. (2023) Searching for Biomarkers in the Blood of Patients at Risk of Developing Parkinson’s Disease at the Prodromal Stage. International Journal of Molecular Sciences 24:3, pages 1842.
Crossref
Lana M. Chahine & Tanya Simuni. 2023. Precision Medicine in Neurodegenerative Disorders, Part II. Precision Medicine in Neurodegenerative Disorders, Part II 325 345 .
Ting Shen, Yumei Yue, Fang Ba, Tinging He, Xiaocui Tang, Xingyue Hu, Jiali Pu, Cong Huang, Wen Lv, Baorong Zhang & Hsin-Yi Lai. (2022) Diffusion along perivascular spaces as marker for impairment of glymphatic system in Parkinson’s disease. npj Parkinson's Disease 8:1.
Crossref
Jing Zhang. (2022) Investigating neurological symptoms of infectious diseases like COVID-19 leading to a deeper understanding of neurodegenerative disorders such as Parkinson's disease. Frontiers in Neurology 13.
Crossref
Pedro Magalhães & Hilal A. Lashuel. (2022) Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson’s disease and other synucleinopathies. npj Parkinson's Disease 8:1.
Crossref
Saima Zafar, Aneeqa Noor, Neelam Younas, Mohsin Shafiq, Matthias Schmitz, Isabel Wurster, Kathrin Brockmann, Thomas Gasser & Inga Zerr. (2022) SWATH Mass Spectrometry-Based CSF Proteome Profile of GBA-Linked Parkinson’s Disease Patients. International Journal of Molecular Sciences 23:22, pages 14166.
Crossref
Edyta Mikuła, Jaroslav Katrlík & Ligia R. Rodrigues. (2022) Electrochemical Aptasensors for Parkinson’s Disease Biomarkers Detection. Current Medicinal Chemistry 29:37, pages 5795-5814.
Crossref
Insup Choi, George R. HeatonYou-Kyung Lee & Zhenyu Yue. (2022) Regulation of α-synuclein homeostasis and inflammasome activation by microglial autophagy. Science Advances 8:43.
Crossref
Qinghui Zhang, Jia Li, Wei Quan, Li Liu, Yidan Qin, Xiaochen Pei, Hang Su, Jing Xu & Jiajun Chen. (2022) CSF α-Synuclein and Tau as Biomarkers for Dementia With Lewy Bodies. Alzheimer Disease & Associated Disorders 36:4, pages 368-373.
Crossref
Annika Kluge, Josina Bunk, Eva Schaeffer, Alice Drobny, Wei Xiang, Henrike Knacke, Simon Bub, Wiebke Lückstädt, Philipp Arnold, Ralph Lucius, Daniela Berg & Friederike Zunke. (2022) Detection of neuron-derived pathological α-synuclein in blood. Brain 145:9, pages 3058-3071.
Crossref
Mai M. Abdelmoaty, Jatin Machhi, Pravin Yeapuri, Farah Shahjin, Vikas Kumar, Katherine E. Olson, R. Lee Mosley & Howard E. Gendelman. (2022) Monocyte biomarkers define sargramostim treatment outcomes for Parkinson's disease. Clinical and Translational Medicine 12:7.
Crossref
Maider Zubelzu, Teresa Morera-Herreras, Gorka Irastorza, Juan Carlos Gómez-Esteban & Ane Murueta-Goyena. (2022) Plasma and serum alpha-synuclein as a biomarker in Parkinson's disease: A meta-analysis. Parkinsonism & Related Disorders 99, pages 107-115.
Crossref
Savannah M. Rocha, Collin M. Bantle, Tawfik Aboellail, Debotri Chatterjee, Richard J. Smeyne & Ronald B. Tjalkens. (2022) Rotenone induces regionally distinct α-synuclein protein aggregation and activation of glia prior to loss of dopaminergic neurons in C57Bl/6 mice. Neurobiology of Disease 167, pages 105685.
Crossref
Luisa Agnello, Bruna Lo Sasso, Matteo Vidali, Concetta Scazzone, Caterina Maria Gambino, Tommaso Piccoli, Giulia Bivona, Anna Maria Ciaccio, Rosaria Vincenza Giglio, Vincenzo La Bella & Marcello Ciaccio. (2022) Evaluation of Alpha-Synuclein Cerebrospinal Fluid Levels in Several Neurological Disorders. Journal of Clinical Medicine 11:11, pages 3139.
Crossref
Marisa Cressatti & Hyman M. Schipper. (2022) Dysregulation of a Heme Oxygenase–Synuclein Axis in Parkinson Disease. NeuroSci 3:2, pages 284-299.
Crossref
Anna Emdina, Peter Hermann, Daniela Varges, Sabine Nuhn, Stefan Goebel, Timothy Bunck, Fabian Maass, Matthias Schmitz, Franc Llorens, Niels Kruse, Paul Lingor, Brit Mollenhauer & Inga Zerr. (2022) Baseline Cerebrospinal Fluid α-Synuclein in Parkinson’s Disease Is Associated with Disease Progression and Cognitive Decline. Diagnostics 12:5, pages 1259.
Crossref
Tsai-Wei Liu, Chiung-Mei Chen & Kuo-Hsuan Chang. (2022) Biomarker of Neuroinflammation in Parkinson’s Disease. International Journal of Molecular Sciences 23:8, pages 4148.
Crossref
Lorenzo Barba, Federico Paolini Paoletti, Giovanni Bellomo, Lorenzo Gaetani, Steffen Halbgebauer, Patrick Oeckl, Markus Otto & Lucilla Parnetti. (2022) Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers. Movement Disorders 37:4, pages 669-683.
Crossref
Ane Murueta-Goyena, Raffaela Cipriani, Mar Carmona-Abellán, Marian Acera, Naia Ayo, Rocío Del Pino, Beatriz Tijero, Tamara Fernández-Valle, Iñigo Gabilondo, Fátima Zallo, Carlos Matute, Rosario Sánchez-Pernaute, Vikram Khurana, Fabio Cavaliere, Estibaliz Capetillo-Zarate & Juan Carlos Gómez-Esteban. (2022) Characterization of molecular biomarkers in cerebrospinal fluid and serum of E46K-SNCA mutation carriers. Parkinsonism & Related Disorders 96, pages 29-35.
Crossref
Münteha Nur Sonuç Karaboğa & Mustafa Kemal Sezgintürk. (2022) Biosensor approaches on the diagnosis of neurodegenerative diseases: Sensing the past to the future. Journal of Pharmaceutical and Biomedical Analysis 209, pages 114479.
Crossref
Alba Cervantes González & Olivia Belbin. (2022) Fluid markers of synapse degeneration in synucleinopathies. Journal of Neural Transmission 129:2, pages 187-206.
Crossref
A. Planas-Ballvé & D. Vilas. (2021) Cognitive Impairment in Genetic Parkinson’s Disease. Parkinson's Disease 2021, pages 1-11.
Crossref
Ju-Young Lee, Hyeo-il Ma & Young Eun Kim. (2021) Biomarker in Parkinson’s Disease: Clinical and Biochemical Biomarker. Journal of the Korean Neurological Association 39:4, pages 287-297.
Crossref
Cristiano Carlomagno, Dario Bertazioli, Alice Gualerzi, Silvia Picciolini, Michele Andrico, Francesca Rodà, Mario Meloni, Paolo Innocente Banfi, Federico Verde, Nicola Ticozzi, Vincenzo Silani, Enza Messina & Marzia Bedoni. (2021) Identification of the Raman Salivary Fingerprint of Parkinson’s Disease Through the Spectroscopic– Computational Combinatory Approach. Frontiers in Neuroscience 15.
Crossref
Federico Angelo Cazzaniga, Edoardo Bistaffa, Chiara Maria Giulia De Luca, Giuseppe Bufano, Antonio Indaco, Giorgio Giaccone & Fabio Moda. (2021) Sporadic Creutzfeldt-Jakob disease: Real-Time Quaking Induced Conversion (RT-QuIC) assay represents a major diagnostic advance. European Journal of Histochemistry 65:s1.
Crossref
Silvia Paciotti, Erik Stoops, Cindy François, Giovanni Bellomo, Paolo Eusebi, Hugo Vanderstichele, Davide Chiasserini & Lucilla Parnetti. (2021) Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement. Clinical Chemistry and Laboratory Medicine (CCLM) 59:10, pages 1653-1661.
Crossref
Adela Ciobanu, Ioana Ionita, Mihaela Buleandra, Iulia David, Dana Popa, Anton Ciucu & Magdalena Budisteanu. (2021) Current advances in metabolomic studies on non‑motor psychiatric manifestations of Parkinson's disease (Review). Experimental and Therapeutic Medicine 22:3.
Crossref
Upasana Ganguly, Sukhpal Singh, Soumya Pal, Suvarna Prasad, Bimal K. Agrawal, Reena V. Saini & Sasanka Chakrabarti. (2021) Alpha-Synuclein as a Biomarker of Parkinson’s Disease: Good, but Not Good Enough. Frontiers in Aging Neuroscience 13.
Crossref
Dan Xie, Ling Feng, Hongyan Huang, Quanzhen Zhao, Pingping Ning, Qiuyan Shen, Haitao Lu, Fang Xu & Yanming Xu. (2021) Cerebrospinal Fluid Biomarkers in Multiple System Atrophy Relative to Parkinson’s Disease: A Meta-Analysis. Behavioural Neurology 2021, pages 1-9.
Crossref
Vsevolod Bogdanov, Alexander Kim, Marina Nodel, Tatiana Pavlenko, Ekaterina Pavlova, Victor Blokhin, Natalia Chesnokova & Michael Ugrumov. (2021) A Pilot Study of Changes in the Level of Catecholamines and the Activity of α-2-Macroglobulin in the Tear Fluid of Patients with Parkinson’s Disease and Parkinsonian Mice. International Journal of Molecular Sciences 22:9, pages 4736.
Crossref
Daniela Perra, Matilde Bongianni, Giovanni Novi, Francesco Janes, Valentina Bessi, Stefano Capaldi, Luca Sacchetto, Matteo Tagliapietra, Guido Schenone, Silvia Morbelli, Michele Fiorini, Tatiana Cattaruzza, Giulia Mazzon, Christina D Orrù, Mauro Catalan, Paola Polverino, Andrea Bernardini, Gaia Pellitteri, Mariarosa Valente, Claudio Bertolotti, Benedetta Nacmias, Giandomenico Maggiore, Tiziana Cavallaro, Paolo Manganotti, Gianluigi Gigli, Salvatore Monaco, Flavio Nobili & Gianluigi Zanusso. (2021) Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodies. Brain Communications 3:2.
Crossref
Ioannis Mavroudis, Foivos Petridis, Symela Chatzikonstantinou & Dimitrios Kazis. (2021) Response to the Letter to the Editor by Tomoyuki Kawada. Alzheimer Disease & Associated Disorders 35:2, pages 187-188.
Crossref
Xavier Morató, Paula Garcia-Esparcia, Josep Argerich, Franc Llorens, Inga Zerr, Wojciech Paslawski, Eva Borràs, Eduard Sabidó, Ulla E. Petäjä-Repo, Víctor Fernández-Dueñas, Isidro Ferrer, Per Svenningsson & Francisco Ciruela. (2021) Ecto-GPR37: a potential biomarker for Parkinson’s disease. Translational Neurodegeneration 10:1.
Crossref
Marthe Smedinga, Sirwan K. L. Darweesh, Bastiaan R. Bloem, Bart Post & Edo Richard. (2020) Towards early disease modification of Parkinson’s disease: a review of lessons learned in the Alzheimer field. Journal of Neurology 268:2, pages 724-733.
Crossref
Raghavendra Upadhya & Ashok K Shetty. (2021) Extracellular Vesicles for the Diagnosis and Treatment of Parkinson’s Disease. Aging and disease 12:6, pages 1438.
Crossref
Cristina Agliardi, Mario Meloni, Franca Rosa Guerini, Milena Zanzottera, Elisabetta Bolognesi, Francesca Baglio & Mario Clerici. (2021) Oligomeric α-Syn and SNARE complex proteins in peripheral extracellular vesicles of neural origin are biomarkers for Parkinson's disease. Neurobiology of Disease 148, pages 105185.
Crossref
Anastasia Bougea. 2021. 97 134 .
Laura Ibanez, Jorge A. Bahena, Chengran Yang, Umber Dube, Fabiana H. G. Farias, John P. Budde, Kristy Bergmann, Carol Brenner-Webster, John C. Morris, Richard J. Perrin, Nigel J. Cairns, John O’Donnell, Ignacio Álvarez, Monica Diez-Fairen, Miquel Aguilar, Rebecca Miller, Albert A. Davis, Pau Pastor, Paul Kotzbauer, Meghan C. Campbell, Joel S. Perlmutter, Herve Rhinn, Oscar Harari, Carlos Cruchaga & Bruno A. Benitez. (2020) Functional genomic analyses uncover APOE-mediated regulation of brain and cerebrospinal fluid beta-amyloid levels in Parkinson disease. Acta Neuropathologica Communications 8:1.
Crossref
Lorenzo Gaetani, Federico Paolini Paoletti, Giovanni Bellomo, Andrea Mancini, Simone Simoni, Massimiliano Di Filippo & Lucilla Parnetti. (2020) CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment. Trends in Pharmacological Sciences 41:12, pages 1023-1037.
Crossref
Eleonora Del Prete, Maria Francesca Beatino, Nicole Campese, Linda Giampietri, Gabriele Siciliano, Roberto Ceravolo & Filippo Baldacci. (2020) Fluid Candidate Biomarkers for Alzheimer’s Disease: A Precision Medicine Approach. Journal of Personalized Medicine 10:4, pages 221.
Crossref
Michael Ugrumov. (2020) Development of early diagnosis of Parkinson's disease: Illusion or reality?. CNS Neuroscience & Therapeutics 26:10, pages 997-1009.
Crossref
Xiaoyu Dong, Dongming Zheng & Jianfei Nao. (2020) Circulating Exosome microRNAs as Diagnostic Biomarkers of Dementia. Frontiers in Aging Neuroscience 12.
Crossref
Jacob Parres-Gold, Andy Chieng, Stephanie Wong Su & Yixian Wang. (2020) Real-Time Characterization of Cell Membrane Disruption by α-Synuclein Oligomers in Live SH-SY5Y Neuroblastoma Cells. ACS Chemical Neuroscience 11:17, pages 2528-2534.
Crossref
Takayuki Katayama, Jun Sawada, Kae Takahashi & Osamu Yahara. (2020) Cerebrospinal Fluid Biomarkers in Parkinson’s Disease: A Critical Overview of the Literature and Meta-Analyses. Brain Sciences 10:7, pages 466.
Crossref
Sophia R.L. Vieira, Marco Toffoli, Philip Campbell & Anthony H.V. Schapira. (2020) Biofluid Biomarkers in Parkinson's Disease: Clarity Amid Controversy. Movement Disorders 35:7, pages 1128-1133.
Crossref
Nicholas J. Ashton, Abdul Hye, Anto P. Rajkumar, Antoine Leuzy, Stuart Snowden, Marc Suárez-Calvet, Thomas K. Karikari, Michael Schöll, Renaud La Joie, Gil D. Rabinovici, Kina Höglund, Clive Ballard, Tibor Hortobágyi, Per Svenningsson, Kaj Blennow, Henrik Zetterberg & Dag Aarsland. (2020) An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders. Nature Reviews Neurology 16:5, pages 265-284.
Crossref
E. A. Katunina, E. P. Ilina, G. I. Sadekhova & E. I. Gaisenuk. (2020) Approaches to the Early Diagnosis of Parkinson’s Disease. Neuroscience and Behavioral Physiology 50:4, pages 393-400.
Crossref
Maja Malmberg, Tarja Malm, Oskar Gustafsson, Andrea Sturchio, Caroline Graff, Alberto J. Espay, Anthony P. Wright, Samir El Andaloussi, Anders Lindén & Kariem Ezzat. (2020) Disentangling the Amyloid Pathways: A Mechanistic Approach to Etiology. Frontiers in Neuroscience 14.
Crossref
Evangelia Emmanouilidou, Nikolaos Papagiannakis, Stella Kouloulia, Aikaterini Galaziou, Roubina Antonellou, Dimitra Papadimitriou, Aglaia Athanasiadou, Maria Bozi, Christos Koros, Matina Maniati, Kostas Vekrellis, Penelope C. Ioannou & Leonidas Stefanis. (2020) Peripheral alpha-synuclein levels in patients with genetic and non-genetic forms of Parkinson's disease. Parkinsonism & Related Disorders 73, pages 35-40.
Crossref
Marisa Cressatti, Lamin Juwara, Julia M. Galindez, Ana M. Velly, Eva S. Nkurunziza, Sara Marier, Olivia Canie, Mervyn Gornistky & Hyman M. Schipper. (2019) Salivary microR‐153 and microR‐223 Levels as Potential Diagnostic Biomarkers of Idiopathic Parkinson's Disease. Movement Disorders 35:3, pages 468-477.
Crossref
Albert A. Davis, Casey E. Inman, Zachary M. WargelUmber Dube, Brittany M. Freeberg, Alexander Galluppi, Jessica N. HainesDhruva D. DhavaleRebecca Miller, Fahim A. Choudhury, Patrick M. Sullivan, Carlos Cruchaga, Joel S. PerlmutterJason D. Ulrich, Bruno A. Benitez, Paul T. Kotzbauer & David M. Holtzman. (2020) APOE genotype regulates pathology and disease progression in synucleinopathy . Science Translational Medicine 12:529.
Crossref
Maria C Edman, Srikanth R Janga, Shruti Singh Kakan, Curtis T Okamoto, Daniel Freire, Danielle Feigenbaum, Mark Lew & Sarah F Hamm-Alvarez. (2020) Tears – more to them than meets the eye: why tears are a good source of biomarkers in Parkinson's disease. Biomarkers in Medicine 14:2, pages 151-163.
Crossref
Parker H. Johnson, Neal J. Weinreb, James C. Cloyd, Paul J. Tuite & Reena V. Kartha. (2020) GBA1 mutations: Prospects for exosomal biomarkers in α-synuclein pathologies. Molecular Genetics and Metabolism 129:2, pages 35-46.
Crossref
Chun-Wei Chang, Shieh-Yueh Yang, Che-Chuan Yang, Chia-Wen Chang & Yih-Ru Wu. (2020) Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease. Frontiers in Neurology 10.
Crossref
Serena Singh & Mari L DeMarco. (2020) In Vitro Conversion Assays Diagnostic for Neurodegenerative Proteinopathies. The Journal of Applied Laboratory Medicine 5:1, pages 142-157.
Crossref
Elena Camporesi, Johanna Nilsson, Ann Brinkmalm, Bruno Becker, Nicholas J Ashton, Kaj Blennow & Henrik Zetterberg. (2020) Fluid Biomarkers for Synaptic Dysfunction and Loss. Biomarker Insights 15, pages 117727192095031.
Crossref
Takayuki Katayama, Jun Sawada, Shiori Kikuchi-Takeguchi, Kohei Kano, Kae Takahashi, Tsukasa Saito, Atsutaka Okizaki & Naoyuki Hasebe. (2020) Cerebrospinal fluid levels of alpha-synuclein, amyloid β, tau, phosphorylated tau, and neuron-specific enolase in patients with Parkinson’s disease, dementia with Lewy bodies or other neurological disorders: Their relationships with cognition and nuclear medicine imaging findings. Neuroscience Letters 715, pages 134564.
Crossref
Eva Schaeffer, Ronald B. Postuma & Daniela Berg. 2020. Recent Advances in Parkinson's Disease. Recent Advances in Parkinson's Disease 331 356 .
Anastasia Bougea. 2020. 137 178 .
Akhlaq A. Farooqui. 2020. Insulin Resistance as a Risk Factor in Visceral and Neurological Disorders. Insulin Resistance as a Risk Factor in Visceral and Neurological Disorders 293 347 .
Angelo Nuti, Cecilia Carlesi, Elena Caldarazzo Ienco, Gabriele Cipriani & Paolo Del Dotto. 2020. Diagnosis and Management in Dementia. Diagnosis and Management in Dementia 225 237 .
Chen Tian, Genliang Liu, Liyan Gao, David Soltys, Catherine Pan, Tessandra Stewart, Min Shi, Zhiying Xie, Na Liu, Tao Feng & Jing Zhang. (2019) Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease. Translational Neurodegeneration 8:1.
Crossref
Wei-Wei Li, Dong-Yu Fan, Ying-Ying Shen, Fa-Ying Zhou, Yang Chen, Ye-Ran Wang, Heng Yang, Jing Mei, Ling Li, Zhi-Qiang Xu & Yan-Jiang Wang. (2019) Association of the Polygenic Risk Score with the Incidence Risk of Parkinson’s Disease and Cerebrospinal Fluid α-Synuclein in a Chinese Cohort. Neurotoxicity Research 36:3, pages 515-522.
Crossref
Matilde Bongianni, Anna Ladogana, Stefano Capaldi, Sigrid Klotz, Simone Baiardi, Annachiara Cagnin, Daniela Perra, Michele Fiorini, Anna Poleggi, Giuseppe Legname, Tatiana Cattaruzza, Francesco Janes, Massimo Tabaton, Bernardino Ghetti, Salvatore Monaco, Gabor G. Kovacs, Piero Parchi, Maurizio Pocchiari & Gianluigi Zanusso. (2019) α‐Synuclein RT‐QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies. Annals of Clinical and Translational Neurology 6:10, pages 2120-2126.
Crossref
Muneera Fayyad, Safa Salim, Nour Majbour, Daniel Erskine, Erik Stoops, Brit Mollenhauer & Omar M. A. El‐Agnaf. (2019) Parkinson’s disease biomarkers based on α‐synuclein. Journal of Neurochemistry 150:5, pages 626-636.
Crossref
Lisa Fellner & Gregor K. Wenning. (2019) Multiple system atrophy – Are cerebrospinal fluid cytokines reliable potential diagnostic marker?. Parkinsonism & Related Disorders 65, pages 1-2.
Crossref
Saranya Sundaram, Rachel L. Hughes, Eric Peterson, Eva M. Müller-Oehring, Helen M. Brontë-Stewart, Kathleen L. Poston, Afik Faerman, Chloe Bhowmick & Tilman Schulte. (2019) Establishing a framework for neuropathological correlates and glymphatic system functioning in Parkinson’s disease. Neuroscience & Biobehavioral Reviews 103, pages 305-315.
Crossref
Lucilla Parnetti, Silvia Paciotti, Lucia Farotti, Giovanni Bellomo, Federica Nicoletta Sepe & Paolo Eusebi. (2019) Parkinson's and Lewy body dementia CSF biomarkers. Clinica Chimica Acta 495, pages 318-325.
Crossref
Wojciech Paslawski, Justyna Zareba-PaslawskaXiaoqun ZhangKatharina HölzlHenrik WadenstenMohammadreza ShariatgorjiShorena JanelidzeOskar HanssonLars Forsgren, Per E. Andrén & Per Svenningsson. (2019) α-synuclein−lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson's disease patients. Proceedings of the National Academy of Sciences 116:30, pages 15226-15235.
Crossref
Sneha Mantri, James F. Morley & Andrew D. Siderowf. (2019) The importance of preclinical diagnostics in Parkinson disease. Parkinsonism & Related Disorders 64, pages 20-28.
Crossref
Fabian Maass, Isabel Schulz, Paul Lingor, Brit Mollenhauer & Mathias Bähr. (2019) Cerebrospinal fluid biomarker for Parkinson's disease: An overview. Molecular and Cellular Neuroscience 97, pages 60-66.
Crossref
Lucilla Parnetti, Lorenzo Gaetani, Paolo Eusebi, Silvia Paciotti, Oskar Hansson, Omar El-Agnaf, Brit Mollenhauer, Kaj Blennow & Paolo Calabresi. (2019) CSF and blood biomarkers for Parkinson's disease. The Lancet Neurology 18:6, pages 573-586.
Crossref
Matthias Schmitz, Anna Villar-Piqué, Franc Llorens, Karin Gmitterová, Peter Hermann, Daniela Varges, Saima Zafar, Paul Lingor, Hugo Vanderstichele, Leentje Demeyer, Erik Stoops, John Q Trojanowski, Virginia M-Y Lee & Inga Zerr. (2018) Cerebrospinal Fluid Total and Phosphorylated α-Synuclein in Patients with Creutzfeldt–Jakob Disease and Synucleinopathy. Molecular Neurobiology 56:5, pages 3476-3483.
Crossref
Orhan Tansel Korkmaz & Neşe Tunçel. (2019) Advantages of Vasoactive Intestinal Peptide for the Future Treatment of Parkinson’s Disease. Current Pharmaceutical Design 24:39, pages 4693-4701.
Crossref
Tino Prell, Otto W. Witte & Julian Grosskreutz. (2019) Biomarkers for Dementia, Fatigue, and Depression in Parkinson's Disease. Frontiers in Neurology 10.
Crossref
Mei Ishiguro, Hajime Baba, Hitoshi Maeshima, Takahisa Shimano, Megumi Inoue, Tomoya Ichikawa, Seita Yasuda, Hiroko Shukuzawa, Toshihito Suzuki & Heii Arai. (2019) Increased Serum Levels of α-Synuclein in Patients With Major Depressive Disorder. The American Journal of Geriatric Psychiatry 27:3, pages 280-286.
Crossref
Lorraine V. Kalia. (2019) Diagnostic biomarkers for Parkinson's disease: focus on α-synuclein in cerebrospinal fluid. Parkinsonism & Related Disorders 59, pages 21-25.
Crossref
Münteha Nur Sonuç Karaboğa & Mustafa Kemal Sezgintürk. (2019) Cerebrospinal fluid levels of alpha-synuclein measured using a poly-glutamic acid-modified gold nanoparticle-doped disposable neuro-biosensor system. The Analyst 144:2, pages 611-621.
Crossref
E. A. Katunina, E. P. Ilina, G. A. Sadekhova & E. I. Gaisenuk. (2019) Approaches to early diagnosis of Parkinson's disease. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 119:6, pages 119.
Crossref
Akhlaq A. Farooqui. 2019. Molecular Mechanisms of Dementia. Molecular Mechanisms of Dementia 113 150 .
Dario Valdinocci, Rowan Radford, Michael Goulding, Junna Hayashi, Roger Chung & Dean Pountney. (2018) Extracellular Interactions of Alpha-Synuclein in Multiple System Atrophy. International Journal of Molecular Sciences 19:12, pages 4129.
Crossref
Albert A. Davis, Cheryl E.G. Leyns & David M. Holtzman. (2018) Intercellular Spread of Protein Aggregates in Neurodegenerative Disease. Annual Review of Cell and Developmental Biology 34:1, pages 545-568.
Crossref
Myung-Sic Chae, Ju Hyun Park, Hyun Woo Son, Kyo Seon Hwang & Tae Geun Kim. (2018) IGZO-based electrolyte-gated field-effect transistor for in situ biological sensing platform. Sensors and Actuators B: Chemical 262, pages 876-883.
Crossref
Alisson Venazzi, Walter Swardfager, Benjamin Lam, José de Oliveira Siqueira, Nathan Herrmann & Hugo Cogo-Moreira. (2018) Validity of the QUADAS-2 in Assessing Risk of Bias in Alzheimer's Disease Diagnostic Accuracy Studies. Frontiers in Psychiatry 9.
Crossref
Manuel Menéndez-González, Huber Padilla-Zambrano, Cristina Tomás-Zapico & Benjamin García. (2018) Clearing Extracellular Alpha-Synuclein from Cerebrospinal Fluid: A New Therapeutic Strategy in Parkinson’s Disease. Brain Sciences 8:4, pages 52.
Crossref
Simona Daniele, Daniela Frosini, Deborah Pietrobono, Lucia Petrozzi, Annalisa Lo Gerfo, Filippo Baldacci, Jonathan Fusi, Chiara Giacomelli, Gabriele Siciliano, Maria Letizia Trincavelli, Ferdinando Franzoni, Roberto Ceravolo, Claudia Martini & Ubaldo Bonuccelli. (2018) α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson’s Disease Patients and Correlate with Disease Severity. Frontiers in Molecular Neuroscience 11.
Crossref
Lorraine V. Kalia. (2018) Biomarkers for cognitive dysfunction in Parkinson's disease. Parkinsonism & Related Disorders 46, pages S19-S23.
Crossref
Tainá M. Marques, Anouke Van Rumund, H. Bea Kuiperij & Marcel M. Verbeek. 2018. Cerebrospinal Fluid in Neurologic Disorders. Cerebrospinal Fluid in Neurologic Disorders 99 113 .
Laura Ibanez, Umber Dube, Benjamin Saef, John Budde, Kathleen Black, Alexandra Medvedeva, Jorge L. Del-Aguila, Albert A. Davis, Joel S. Perlmutter, Oscar Harari, Bruno A. Benitez & Carlos Cruchaga. (2017) Parkinson disease polygenic risk score is associated with Parkinson disease status and age at onset but not with alpha-synuclein cerebrospinal fluid levels. BMC Neurology 17:1.
Crossref
Lana M. Chahine & Matthew B. Stern. (2017) Parkinson's Disease Biomarkers: Where Are We and Where Do We Go Next?. Movement Disorders Clinical Practice 4:6, pages 796-805.
Crossref
Dag Aarsland, Anto P Rajkumar & Abdul Hye. (2017) Novel evidence associates higher plasma α-synuclein levels and cognitive impairment in Parkinson’s disease. Journal of Neurology, Neurosurgery & Psychiatry 88:10, pages 808-808.
Crossref
Paolo Eusebi, David Giannandrea, Leonardo Biscetti, Iosief Abraha, Davide Chiasserini, Massimiliano Orso, Paolo Calabresi & Lucilla Parnetti. (2017) Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis. Movement Disorders 32:10, pages 1389-1400.
Crossref
Dario Valdinocci, Rowan Radford, Sue Siow, Roger Chung & Dean Pountney. (2017) Potential Modes of Intercellular α-Synuclein Transmission. International Journal of Molecular Sciences 18:2, pages 469.
Crossref
Cristian Falup-Pecurariu & Ştefania Diaconu. 2017. Nonmotor Parkinson's: The Hidden Face - The Many Hidden Faces. Nonmotor Parkinson's: The Hidden Face - The Many Hidden Faces 719 742 .
Iskandar Johar, Brit Mollenhauer & Dag Aarsland. 2017. Parkinson's Disease. Parkinson's Disease 275 294 .
Takahiko Tokuda, Ryotaro Ishii, Harutsugu Tatebe, Takashi Kasai & Omar M. A. El-Agnaf. 2017. Dementia with Lewy Bodies. Dementia with Lewy Bodies 171 192 .
Christine A. Cooper & Lama M. Chahine. (2016) Biomarkers in Prodromal Parkinson Disease: a Qualitative Review. Journal of the International Neuropsychological Society 22:10, pages 956-967.
Crossref
Franc Llorens, Matthias Schmitz, Daniela Varges, Niels Kruse, Nadine Gotzmann, Karin Gmitterov?Brit Mollenhauer & Inga Zerr. (2016) Cerebrospinal ?-synuclein in ?-synuclein aggregation disorders: tau/?-synuclein ratio as potential biomarker for dementia with Lewy bodies. Journal of Neurology 263:11, pages 2271-2277.
Crossref
Saurav Brahmachari, Preston Ge, Su Hyun Lee, Donghoon Kim, Senthilkumar S. Karuppagounder, Manoj Kumar, Xiaobo Mao, Joo Ho Shin, Yunjong Lee, Olga Pletnikova, Juan C. Troncoso, Valina L. Dawson, Ted M. Dawson & Han Seok Ko. (2016) Activation of tyrosine kinase c-Abl contributes to ?-synuclein?induced neurodegeneration. Journal of Clinical Investigation 126:8, pages 2970-2988.
Crossref
Anne Stuendl, Marcel Kunadt, Niels Kruse, Claudia Bartels, Wiebke Moebius, Karin M. Danzer, Brit Mollenhauer & Anja Schneider. (2016) Induction of ?-synuclein aggregate formation by CSF exosomes from patients with Parkinson?s disease and dementia with Lewy bodies. Brain 139:2, pages 481-494.
Crossref
Vanesa Bellou, Lazaros Belbasis, Ioanna Tzoulaki, Evangelos Evangelou & John P.A. Ioannidis. (2016) Environmental risk factors and Parkinson's disease: An umbrella review of meta-analyses. Parkinsonism & Related Disorders 23, pages 1-9.
Crossref
Lucilla Parnetti, Claudia Cicognola, Paolo Eusebi & Davide Chiasserini. (2016) Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosis. Biomarkers in Medicine 10:1, pages 35-49.
Crossref
Lingjia Xu & Jiali Pu. (2016) Alpha-Synuclein in Parkinson’s Disease: From Pathogenetic Dysfunction to Potential Clinical Application. Parkinson's Disease 2016, pages 1-10.
Crossref
Joakim Bergström & Martin Ingelsson. 2016. Immunotherapy and Biomarkers in Neurodegenerative Disorders. Immunotherapy and Biomarkers in Neurodegenerative Disorders 215 234 .
Danielle D. Feng, Waijiao Cai & Xiqun Chen. (2015) The associations between Parkinson’s disease and cancer: the plot thickens. Translational Neurodegeneration 4:1.
Crossref
Philipp Mahlknecht, Klaus Seppi & Werner Poewe. (2015) The Concept of Prodromal Parkinson’s Disease. Journal of Parkinson's Disease 5:4, pages 681-697.
Crossref
Franc Llorens, Niels Kruse, Matthias Schmitz, Mohsin Shafiq, José Eriton Gomes da Cunha, Nadine Gotzman, Saima Zafar, Katrin Thune, João Ricardo Mendes de Oliveira, Brit Mollenhauer & Inga Zerr. (2015) Quantification of CSF biomarkers using an electrochemiluminescence-based detection system in the differential diagnosis of AD and sCJD. Journal of Neurology 262:10, pages 2305-2311.
Crossref
Camilla Steen Jensen, Steen Gregers Hasselbalch, Gunhild Waldemar & Anja Hviid Simonsen. (2015) Biochemical Markers of Physical Exercise on Mild Cognitive Impairment and Dementia: Systematic Review and Perspectives. Frontiers in Neurology 6.
Crossref
Chin-Hsien Lin & Ruey-Meei Wu. (2015) Biomarkers of cognitive decline in Parkinson's disease. Parkinsonism & Related Disorders 21:5, pages 431-443.
Crossref
Bo Zhou, Min Wen, Wen-Feng Yu, Chun-Lin Zhang & Ling Jiao. (2015) The Diagnostic and Differential Diagnosis Utility of Cerebrospinal Fluid ? -Synuclein Levels in Parkinson?s Disease: A Meta-Analysis . Parkinson's Disease 2015, pages 1-11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.